ALAM
PFE icon

Asahi Life Asset Management’s Pfizer PFE Stock Holding History

Asahi Life Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$606K Sell
21,579
-3,364
-13% -$89.6K 0.39% 51
2025
Q4 		$621K Hold
24,943
– – 0.35% 58
2025
Q3 		$636K Buy
+24,943
New +$616K 0.35% 53
2025
Q2 		– Sell
-10,850
Closed -$275K – 193
2025
Q1 		$275K Sell
10,850
-720
-6% -$18.8K 0.18% 152
2024
Q4 		$307K Sell
11,570
-11,080
-49% -$301K 0.19% 140
2024
Q3 		$655K Buy
22,650
+2,340
+12% +$68.3K 0.4% 48
2024
Q2 		$568K Sell
20,310
-2,060
-9% -$56.7K 0.39% 50
2024
Q1 		$621K Buy
+22,370
New +$621K 0.37% 46
2023
Q4 		– Sell
-20,230
Closed -$671K – 221
2023
Q3 		$671K Buy
20,230
+1,260
+7% +$44.6K 0.23% 51
2023
Q2 		$696K Sell
18,970
-760
-4% -$29.6K 0.23% 52
2023
Q1 		$805K Sell
19,730
-300
-1% -$13K 0.26% 50
2022
Q4 		$1.03M Buy
20,030
+490
+3% +$23.5K 0.34% 46
2022
Q3 		$855K Buy
19,540
+360
+2% +$17.5K 0.26% 45
2022
Q2 		$1.01M Buy
19,180
+11,120
+138% +$567K 0.27% 45
2022
Q1 		$417K Buy
8,060
+300
+4% +$15.6K 0.06% 118
2021
Q4 		$458K Sell
7,760
-50
-0.6% -$2.48K 0.06% 105
2021
Q3 		$336K Sell
7,810
-12,260
-61% -$543K 0.05% 132
2021
Q2 		$786K Buy
20,070
+2,760
+16% +$107K 0.11% 52
2021
Q1 		$627K Sell
17,310
-10,870
-39% -$386K 0.09% 65
2020
Q4 		$1.04M Sell
28,180
-152
-0.5% -$5.58K 0.13% 58
2020
Q3 		$986K Sell
28,332
-127,972
-82% -$4.49M 0.15% 43
2020
Q2 		$4.85M Sell
156,304
-15,312
-9% -$520K 0.8% 33
2020
Q1 		$5.32M Buy
171,616
+11,025
+7% +$376K 0.95% 32
2019
Q4 		$5.97M Buy
160,591
+10,915
+7% +$389K 0.88% 32
2019
Q3 		$5.1M Buy
149,676
+36,566
+32% +$1.33M 0.83% 33
2019
Q2 		$4.65M Sell
113,110
-36,042
-24% -$1.43M 0.93% 33
2019
Q1 		$6.01M Sell
149,152
-28,947
-16% -$1.16M 0.98% 30
2018
Q4 		$7.38M Buy
+178,099
New +$7.39M 1.15% 29

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Asahi Life Asset Management's PFE Position: Q1 2026 in Review

Asahi Life Asset Management reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $89.6K and leaving 21,579 shares worth $606K. The position accounts for 0.39% of the portfolio, ranked #51.

Asahi Life Asset Management first reported a position in PFE in Q4 2018 and has held it in 28 quarters since. The position peaked at $7.38M in Q4 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Asahi Life Asset Management held 21,579 shares of Pfizer worth $606K as of Q1 2026.
  • Asahi Life Asset Management sold 3,364 Pfizer shares in Q1 2026, an estimated $89.6K.
  • Pfizer made up 0.39% of Asahi Life Asset Management's portfolio in Q1 2026, its #51 holding.
  • Asahi Life Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 28 quarters since.
  • Asahi Life Asset Management's Pfizer position peaked at $7.38M in Q4 2018.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Asahi Life Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.